Lawrence Berkeley National Lab is hiring for Full Time 2023 Luis J. Alvarez and Admiral Grace M. Hopper Postdoc Fellowship in Computing Sciences - San Francisco, CA - a Mid-level AI/ML/Data Science role offering benefits such as Career development, Competitive pay, Equity, Relocation support

A recent study published in IEEE Intelligent Systems discussed the role of artificial intelligence (AI) in combating the coronavirus disease 2019 (COVID-19) pandemic. The COVID-19 pandemic has reshaped the world in an unprecedented way, resulting in more than 583 million cases and six million deaths to date. Yet, there is no clear sign of an end to the ongoing crisis. AI has been instrumental during the pandemic in supporting telemedicine, communications, automated, virtual, and economic activities. AI has been at the center of the fight against COVID-19 from detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent, identifying COVID-19 symptoms to saving lives and curtailing the spread of the virus.

With the support of various machine learning methods, many RV and SV approaches have been developed and applied to COVID-19 vaccine design.

Despite digital finance being well-established way before the onset of the coronavirus pandemic, like many industries, COVID-19 has accelerated the pace of change within FinTech as the demand for online banking continues to rise. With this change comes the introduction of artificial intelligence (AI) and machine learning (ML) which have been among the key drivers of growth and sustainability for financial companies. Here, AI Magazine looks at three different ways AI can be applied within finance to harness growth and boost productivity. Fraudulent transactions cost economies a significant amount of money every single year and are a significant problem for many financial institutions globally. Not only does fraud financially impact companies but can also be damaging to a FinTech companies' reputation.

Amar Gupta of MIT's Computer Science and Artificial Intelligence Laboratory discusses the increase in virtual care driven by Covid-19 and the need …

COVID-19 Vaccination: GDIT does not have a vaccination mandate applicable to all employees. To protect the health and safety of its employees and to comply with customer requirements, however, GDIT may require employees in certain positions to be fully vaccinated against COVID-19. Vaccination requirements will depend on the status of the federal contractor mandate and customer site requirements.

Role requiring'No experience data provided' months of experience in Newark At Lucid, we don't just welcome diversity – we celebrate it! Lucid Motors is proud to be an equal opportunity workplace. We are committed to equal employment opportunity regardless of race, color, national or ethnic origin, age, religion, disability, sexual orientation, gender, gender identity and expression, marital status, and any other characteristic protected under applicable State or Federal laws and regulations. In response to the novel Coronavirus all new Lucid employees, whose job will be based in the United States may or may not be required to provide original documentation confirming status as having received the prescribed inoculation (doses). Vaccination requirements are dependent upon location and position, please refer to the job description for more details.

China's export growth continued to rise in July, sending trade surplus to a record high, according to government data. China's exports grew 18% to $333 billion compared to the same period last year, and were up from 17.9% in June, according to data from China's customs. Imports, however, remained soft, growing 2.3% in July compared to a year ago. That was lower that economists' estimates of 4%, and suggests weak domestic demand amid lockdowns across the country as China attempts to stem the outbreak of COVID-19. China's total trade surplus reached an all-time high of $101.3 billion in July, breaking the record set in June.

In early 2020, when scientists rushed to develop a vaccine to take on the SARS-CoV-2 coronavirus that causes COVID-19, it seemed like a really long shot. The fastest a vaccine had ever previously been developed was for mumps, back in the 1960s--an effort that took 48 months. Still, just nine months later, in December 2020, the American pharmaceutical giant Pfizer and a German deep-tech startup, BioNTech, had developed the first COVID-19 vaccine, validating the use of the new technology of mRNA-based vaccines. The first studies on DNA vaccines began 25 years ago, and the science of RNA vaccines too has been evolving for over 15 years. One outcome was mRNA technology, which required the convergence of advances in synthetic biology, nanotechnology, and artificial intelligence, and has transformed the science--and the business--of vaccines.

As a Customer Success Manager you will be on point and responsible for building and maintaining relationships with Collibra's Data Quality customers. You'll serve as a trusted advisor, helping customers drive adoption, move along the maturity curve and derive value from our solution. You will have an integral position within Collibra, working closely with Sales, Professional Services, Support, Product Management, and Customer Success to ensure our customer's success - ultimately securing the renewal and driving growth. We strive to provide all Collibrians with competitive and cost-efficient benefits that are aligned to our company values. As a high-growth company, our goal is to offer flexibility and choice with our benefits programs to support the evolving needs of our changing workforce.